[Oxaliplatinum in combination with 5-FU/FA in first-line chemotherapy of metastatic colorectal cancer: a new era in therapeutic strategy].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D010070:Oxalates / Q000627:therapeutic use*; D017671:Platinum Compounds / Q000627:therapeutic use*; D016019:Survival Analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D010070:Oxalates; D017671:Platinum Compounds; D005472:Fluorouracil
Oxaliplatino in associazione con 5-FU/FA in chemioterapia nel trattamento di prima linea del tumore colorettale metastatico: una nuova era nella strategia terapeutica.